Territorial Availability: Available through Bertin Technologies only in France
- Synonyms
- 2-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine, monohydrochloride
- Correlated keywords
- 446859-33-2 1450722-69-6 TGF-?1 receptors serine/threonine kinases ALK5 inhibitors E 616452 RepSox SJN 2511 stem cells pluripotency reprogramming Sox2 Nanog TGFs ser/thr serines threonine ALK-5 ALKs 5 five inhibits inhibitions E-616452 S616452 SJN-2511 SJN2511 Rep Sox Rep-Sox Soxs 2 two Sox-2 biology intracellular signaling research biochemistry permeable selective autophosphorylation HepG2 p38 MAPK GSK3 transcription factors pathways TGF-?1 HCl Nanog reprogramming
- Product Overview:
ALK5 inhibitor II is a cell permeable, selective inhibitor of the TGF-? type 1 activin like kinase receptor ALK5 (IC50s = 4, 18, and 23 nM for ALK5 autophosphorylation, TGF-? cellular assay, and ALK5 binding in HepG2 cells, respectively).{23565} This inhibitor demonstrated less potent activity (IC50s > 16 ?M) when tested against a panel of 9 related kinases, including p38 MAPK and GSK3.{23565} At 25 ?M, this compound has been used to induce stem cell pluripotency by replacing the reprogramming transcription factor Sox2 via inhibition of the TGF-? signaling pathway and induction of Nanog transcription.{23566} This product is a hydrochloride form of the compound. A non-hydrochloride version of ALK5 inhibitor II (Item No. 14794) is also available.
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.